TGA Seeks Independent Review on Rescheduling of Psilocybin and MDMA as Part of Therapy in Medically Controlled Environments
Mind Medicine Australia, April 8, 2021
The TGA announced that the Scheduling Delegate has decided to seek further advice in relation to Mind Medicine Australia’s applications to reschedule psilocybin and MDMA as part of therapy in medically controlled environments.
Your Psychedelic Healing Stories Can Help Change and Save Lives
Mind Medicine Australia, March 24, 2021
We’re putting together a special book about psychedelics in Australia, the first of its kind – filled with incredible and inspirational stories of people who’ve changed their lives through psychedelic medicines like psilocybin and MDMA.
Australia’s Federal system blocking psychedelic treatments for mental illness
Mind Medicine Australia, March 17, 2021
Mind Medicine Australia welcomes the Government’s announcement to provide $15 million for the development of innovative therapies for mental illness.
Mind Medicine Australia urges TGA to reverse its Interim Decision on scientific and humanitarian grounds
Mind Medicine Australia, March 10, 2021
Mind Medicine Australia has just made its final submissions to the TGA opposing their interim decision NOT to reschedule psilocybin and MDMA as Controlled Medicines. A comparison with other substances listed in Schedule 8 of the Poisons Standard indicates that this is the right schedule for the medical use of these substances in controlled medical environments.
Mind Medicine Australia Announces Second Screening of Acclaimed Film Fantastic Fungi in Byron Bay
Mind Medicine Australia, March 8, 2021
Mind Medicine Australia is thrilled to announce our second screening of Fantastic Fungi at 6:30pm on Tuesday March 30th at Byron Theatre in Byron Bay followed by a Q & A Panel and conversation. This is a second screening as the first screening has sold out.
Mind Medicine Australia Announces First Ever Event In Canberra – Screening of the World Acclaimed Film Trip of Compassion
Mind Medicine Australia, February 19, 2021
Mind Medicine Australia is thrilled to announce our first ever screening of Trip of Compassion at 6:30pm on Wednesday March 3rd at Palace Electric Cinema in Canberra followed by a Q&A Panel and discussion.
Mind Medicine Australia challenges TGA Interim Decision
Mind Medicine Australia, February 17, 2021
Mind Medicine Australia urgently needs your support to ensure the Rescheduling Applications for the Medicinal Use of Psilocybin and MDMA are approved by the Government in Canberra.
Mind Medicine Australia Prepares to Contest TGA’s Interim Decision Not to Reschedule Psilocybin and MDMA for Medical Use as Part of Therapy for Key Mental Illnesses
Mind Medicine Australia, February 3, 2021
Mind Medicine Australia prepares to contest TGA’s interim decision not to reschedule psilocybin and MDMA for medical use as part of therapy for key mental illnesses.
Mind Medicine Australia Anticipates Interim Decision Regarding Australia’s First Applications to Reschedule Psilocybin and MDMA for Medical Use as Part of Therapy for Key Mental Illnesses to be Announced on February 3
Mind Medicine Australia, January 12, 2021
Mind Medicine Australia awaits the Therapeutic Goods Administration’s (TGA) interim decision on the rescheduling of psilocybin and MDMA to be used as part of clinical therapy for the treatment of major classes of mental illness. If approved, this would reclassify the medicines from Schedule 9 (Prohibited Substance) of the Standard for the Uniform Scheduling of Medicines and Poisons, to Schedule 8 (Controlled Medicine).
World Famous Author & Physician Dr Gabor Mate Joins Global and Australian Leaders on MMA Advisory Board
Mind Medicine Australia, December 2, 2020
World Famous Author & Physician Dr Gabor Mate Joins More Than 55 Global and Australian Leaders on Mind Medicine Australia’s Advisory Board. Dr Gabor Mate joins a diverse group of global and Australian leaders including Anthropologist Dr Wade Davis CM (Canada), Islamic Scholar and Imam Mohammad Tawhidi, Founder and Director of the Beckley institute Amanda Feilding (UK), Psychedelics researcher Dr Robin Carhart-Harris (UK), Psychiatrist Tanveer Ahmed, Human Rights Lawyer Scott Leckie and many others.
ASX Media Release: Emyria partners with Mind Medicine Australia to develop national care program and data registry for psychedelic-assisted therapies
ASX, November 19, 2020
Mind Medicine Australia partners with Emyria (ASX: EMD) to develop national care program and data registry for psychedelic-assisted therapies.
Australian charity paving the way in psychedelic-assisted therapy launches FREE online webinar series during Mental Health Month
Mind Medicine Australia, October 12, 2020
World-leading experts are brought straight into Australia’s living rooms for discussion about the ground breaking opportunity psychedelic-assisted therapies offer us, and the solutions needed to address problems caused by long-term reliance on pharmaceuticals for mental health treatment.
Mind Medicine Australia Shines a Light on Breakthrough Therapies for Mental Health this Mental Health Month
Mind Medicine Australia, October 8, 2020
Mind Medicine Australia Shines a Light on Breakthrough Therapies for Mental Health this Mental Health Month.
Covid-19 Significant Societal and Mental Health Impacts Highlights Urgent Need for Innovation in Treatments for Mental Illness
Mind Medicine Australia, September 30, 2020
Mind Medicine Australia exists to help alleviate the suffering caused by mental illness in Australia through expanding the treatment options available to medical practitioners and their patients. We already had a major mental health epidemic prior to this pandemic, and this is being severely exacerbated as noted. New treatments are urgently needed to heal those who have and are being damaged by this major crisis.
Mind Medicine Australia Submits Australian-First Application for the Rescheduling of Psilocybin and MDMA
Mind Medicine Australia, September 1, 2020
Mind Medicine Australia has submitted Australia’s first applications to the Therapeutic Goods Administration (TGA) to reschedule Psilocybin and MDMAso that they can be more easily used as part of clinical therapies for the treatment of major classes of mental illness.
ACT Support for Breakthrough Psychedelic-assisted Mental Health Therapies in Upcoming Election
Mind Medicine Australia, August 1, 2020
Mind Medicine Australia welcomes the announcement of the ACT Greens in supporting the development of psychedelic-assisted therapies for the treatment of mental illness in its recently announced drug law reform policy platform.
Mind Medicine Australia Announces First in Southern Hemisphere – Certificate in Psychedelic-Assisted Therapies
Mind Medicine Australia, June 1, 2020
Mental health charity Mind Medicine Australia (MMA) has announced the, first of its kind in the southern hemisphere, Certificate in Psychedelic-Assisted Therapies (CPAT).
Mind Medicine Australia calls for URGENT Mental Health Innovation Taskforce to tackle the mental health pandemic sparked by Covid-19
Mind Medicine Australia, April 6, 2020
Mental health charity Mind Medicine Australia (MMA) calls for and strongly supports all recommendations to form a Mental Health Innovation Taskforce to be immediately established in order to guide the government in planning the next steps to manage the increasing mental health pandemic triggered by Covid-19 and the recent bushfires tragedy.
Urgent Need to Establish a Government-Appointed Steering Group to Fast-Track Consideration of Medicine-Assisted Psychotherapies in Australia
Mind Medicine Australia, February 24, 2020
Mind Medicine Australia (MMA), an Australian-registered charity established to support the development of research-backed and regulatory-approved medicine-assisted psychotherapy in Australia, has publicly released its written submission to the Australian Productivity Commission (APC) in relation to its current inquiry into mental health. The document can be read on the APC Commission website here.
Mind Medicine Australia celebrates its First Anniversary
Mind Medicine Australia, February 12, 2020
Today, Mind Medicine Australia turns one year old! In our first year, we have made remarkable progress in growing public awareness of Medicine-Assisted Therapy in Australia. We are already seeing a paradigm shift in the curiosity, acceptance, and interest into the use of medicine-assisted therapy for depression, addiction, PTSD, obsessive-compulsive disorder, anorexia and other challenges in our communities.